TANKE BIOSCIENCES CORP
Income Statement
| Line Item | FY2012 | FY2011 | FY2010 |
|---|---|---|---|
| Revenue | $28.6M | $23.8M | $20.1M |
| Cost of Revenue | $18.6M | $15.1M | $12.7M |
| Gross Profit | $9.9M | $8.8M | $7.4M |
| Gross Margin | 34.8% | 36.8% | 36.8% |
| Operating Expenses | |||
| Research & Development | $290.7K | $246.0K | — |
| SG&A Expense | $2.6M | $4.5M | $834.8K |
| Operating Income | $4.5M | $1.7M | $4.4M |
| Operating Margin | 15.9% | 7.3% | 21.8% |
| Interest Expense | $1.4M | $1.4M | $100.3K |
| Pretax Income | $602.6K | $-2.5M | $4.3M |
| Income Tax Expense | $831.6K | $681.3K | $582.5K |
| Net Income | $-210.2K | $-3.1M | $2.7M |
| Net Margin | -0.7% | -13.2% | 13.6% |
| EPS (Basic) | $-0.02 | $-0.24 | $0.34 |
| EPS (Diluted) | $-0.02 | $-0.24 | $0.34 |
| Shares Outstanding (Basic) | 13.3M | 13.1M | 10.8M |
| Shares Outstanding (Diluted) | 13.3M | 13.1M | 10.8M |
| Dividends Per Share | — | — | — |